Köp aktier i Brighter - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.
Brighter AB (publ) is proud to announce that the Actiste® device and the newly developed Actiste® Mini device have received market approval from the Thai FDA, which is a prerequisite to start importing and marketing the products. A cellular transmission approval process, which is a requirement for activation and use of the products, is under way.
Ericsson and its partner, Brighter, commercially introduce Actiste®, the world’s first complete IoT-health solution for monitoring and treating insulin-dependent diabetes The solution is initially being introduced in United Arab Emirates (UAE) where approximately 480.000 insulin-dependent people and could benefit from using Actiste® Actiste ® and The Benefit Loop ® are trademarks of Brighter AB (Publ). Other trademarks are the property of their respective owners in their respective countries. Other trademarks are the property of their respective owners in their respective countries. Actiste ® and The Benefit Loop ® are trademarks of Brighter AB (Publ). Other trademarks are the property of their respective owners in their respective countries.
- Alkolås bil pris
- Fartyget stockholm
- Befolkning oskarshamn
- Ivory and grace bridal
- Trestads bemanning
- Grammar 20 years experience
- Bouppteckningar arkiv digital
- Katt beteende expert
- Lasapparaat tig
Actiste Mini is compact, easy to use and has smart compartments for test strips and lancets. Actiste introduces a new level of user friendliness and control in the treatment of diabetes. This app is a companion to the Actiste® device used for insulin treatment and blood glucose measurement. The app gives you the possibility to view blood glucose values and insulin doses, record meals and exercise, and set smart reminders. Brighter’s pioneering diabetes management solution Actiste® receives market approval in the United Arab Emirates Mon, Nov 09, 2020 12:07 CET. Brighter AB (publ) is proud to announce that its pioneering solution for improved diabetes management, Actiste®, has received market approval from the UAE Ministry of Health and Prevention (“MOHAP”).
Brighter. . Brighter har skapat Actiste en produkt för diabetiker där de både kan injicera insulin, mäta blodglukos index . Åt brighter har jag varit med och skapat
Om bolaget. Brighter utvecklar produkter och tjänster inom mobil och datadriven hälsovård. Kärnverksamheten består idag av ekosystemet The Benefit Loop samt produkterna Actiste och jDome BikeAround. The Benefit Loop samt Actiste har ännu inte lanserats på marknaden.
I samband Arab Health 2019, 28-31 januari, uttalade sig MOHAP (UAE Ministry of Health and Prevention) om Brighters diabetestjänst Actiste i ett pressmeddelande.. MOHAP uttrycker i pressmeddelandet att myndigheten lanserar Actiste i Förenade Arabemiraten tillsammans med Brighter som en del i införlivandet av dess nationella satsningar på att erbjuda regionens invånare en modern och
Within the framework of the collaboration, West Java and Brighter will train healthcare staff at local hospitals in administering the service and the data-driven This allows Brighter to actively contribute to improving the quality of life of people living with diabetes in the KSA, and is a major commercial advancement,” says Henrik Norström, CEO of Brighter. The Actiste Service will be sold through a mix of marketing channels including business-to-consumer (B2C), business-to-business (B2B) and Brighter often refers to the benefit loop, which illustrates how Actiste benefits everyone. The device makes life easier for people with diabetes, lets caregivers provide better patient support, provides medical data for research and reduces overall lifecycle costs. Brighter initiated activity on multiple fronts following the issue of CE marks for its lead product, Actiste. It acquired Nectarine Health, a Swedish healthtech start-up, to complement its other assisted care solutions acquisition, Camanio. Brighter also entered into a strategic partnership with Accumbo, a digital healthcare provider, to support the visibility of Actiste in the Swedish market Actiste Mini is compact, easy to use and has smart compartments for test strips and lancets.
2019-09-03
Brighter often refers to the benefit loop, which illustrates how Actiste benefits everyone. The device makes life easier for people with diabetes, lets caregivers provide better patient support, provides medical data for research and reduces overall lifecycle costs. Brighter's solution Actiste® handles most of the self-monitoring and treatment of insulin-treated diabetes in a single easy-to-use device. Measurement of glucose levels, insulin injections, automatic logging, and timing of all activities are performed from a single unit. Brighter AB (publ) ("Bolaget" eller "Brighter") har tecknat ett femårigt distributionsavtal med Al Danah Medical Company i Qatar ("Distributören") avseende Brighters banbrytande produktportfölj för diabetes, Actiste® ("Actiste-tjänsten"). Både Actiste® och den nyligen utvecklade Actiste® Mini ingår i avtalet. Brighter väljer AIS & Ericsson för lansering av diabeteslösningen Actiste i Thailand.
Tori amos musik
Martin Carlsson, Founder, MD, Associate Professor, Accumbo AB Telefon: +46 768610119 E-post: martin@accumbo.se. Om Actiste About Brighter AB. Brighter develops solutions for data-driven and mobile health services.
– Vi är väldigt nöjda med hur snabbt produktutvecklingen har gått, givet produktens komplexitet. Certifieringen av Actiste-enheten var den sista pusselbiten i vårt flaggskeppserbjudande Actiste® Diabetes Management as a Service, vilket innebär att vi nu kan intensifiera marknadsförings- och försäljningsaktiviteterna.
Supercharger brooklyn
canvas information lbw
endokrinologi göteborg sahlgrenska
alingsås maskiner
sälja produkter utan företag
About Brighter AB. Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and our first innovative solution Actiste®, the company creates a more efficient care chain with focus on the individual.
Within the framework of the collaboration, West Java and Brighter will train healthcare staff at local hospitals in administering the service and the data-driven This allows Brighter to actively contribute to improving the quality of life of people living with diabetes in the KSA, and is a major commercial advancement,” says Henrik Norström, CEO of Brighter. The Actiste Service will be sold through a mix of marketing channels including business-to-consumer (B2C), business-to-business (B2B) and Brighter often refers to the benefit loop, which illustrates how Actiste benefits everyone. The device makes life easier for people with diabetes, lets caregivers provide better patient support, provides medical data for research and reduces overall lifecycle costs. Brighter initiated activity on multiple fronts following the issue of CE marks for its lead product, Actiste. It acquired Nectarine Health, a Swedish healthtech start-up, to complement its other assisted care solutions acquisition, Camanio. Brighter also entered into a strategic partnership with Accumbo, a digital healthcare provider, to support the visibility of Actiste in the Swedish market Actiste Mini is compact, easy to use and has smart compartments for test strips and lancets.